Tokushima University Hospital has completed the first TUFF-IPC autologous transplant. What type 1 diabetes involves, the limits of islet transplantation, how the adipose-derived approach works, and why this remains early-stage clinical research.
Japan’s National Cancer Center is running a Phase I/II basket trial of BNCT for thoracic solid tumours. The trial design, who it is recruiting, how BNCT works, and the limitations patients should keep in mind.
Southern Tohoku General Hospital signed MOUs at a Shanghai medical-tourism exhibition, including with Shanghai Jiahui International Hospital. What this means in practice for patients in China looking into BNCT, proton therapy and cross-border care.
Based on published material from Nippon Medical School Hospital and its Yaesu health-screening centre: its role as a designated-function hospital, and its lung-cancer, gastrointestinal surgery, cardiovascular emergency, thyroid surgery and precision health-check systems.
An overview of Japan’s pharmaceutical industry for global buyers — market size, leading manufacturers such as Takeda, Daiichi Sankyo, Chugai, Astellas and Otsuka, and the country’s R&D strengths.
How Japan regulates pharmaceuticals, quasi-drugs and health products under the PMD Act, the roles of MHLW and PMDA, and what international institutional buyers should prepare before importing.
Kampo is traditional Japanese herbal medicine and a regulated part of mainstream healthcare in Japan — 148 formulas are insurance-covered. Learn what it is, how it is standardized, and what institutional buyers should know.
